Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2944
Selected: 0
NCT IDTitle
NCT03063450CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma
NCT03439891Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer
NCT00112580MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
NCT02617589An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
NCT00207168To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine
NCT01750580Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor
NCT00388427Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies
NCT07608731Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
NCT00859053Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment
NCT01332227Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients
NCT05918666National Register of Actionable Mutations
NCT00799045Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects
NCT02089061Drug Interaction Statin
NCT02461602Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
NCT01354431BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
NCT01294436Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
NCT00002067A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
NCT01714739A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors
NCT00927875A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
NCT00000963A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
NCT00211263Bipolar Disorder Research Study for Ages 12 and Older
NCT03252600Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
NCT04209114A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer
NCT00279734Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
NCT00277199Comparability DE vs CD-CHO1
NCT03508271Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT04075604A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer
NCT05088889Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
NCT03071133Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy
NCT05219435Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
NCT00095238Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
NCT03784040Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.
NCT02705833Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02375555Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
NCT00867048Strategic Timing of Antiretroviral Treatment
NCT03695250BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
NCT07226817A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
NCT02754726Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT00243178Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
NCT01221636Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept
NCT03906071Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
NCT02068053Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020
NCT00662545Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
NCT06160167Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs
NCT00908271Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects
NCT03788044Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
NCT03586999Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
NCT00279409Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
NCT01137851Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients
NCT00930865Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects